Arab, H.H.; Khames, A.; Mohammad, M.K.; Alsufyani, S.E.; Ashour, A.M.; El-Sheikh, A.A.K.; Darwish, H.W.; Gad, A.M.
Meloxicam Targets COX-2/NOX1/NOX4/Nrf2 Axis to Ameliorate the Depression-like Neuropathology Induced by Chronic Restraint Stress in Rats. Pharmaceuticals 2023, 16, 848.
https://doi.org/10.3390/ph16060848
AMA Style
Arab HH, Khames A, Mohammad MK, Alsufyani SE, Ashour AM, El-Sheikh AAK, Darwish HW, Gad AM.
Meloxicam Targets COX-2/NOX1/NOX4/Nrf2 Axis to Ameliorate the Depression-like Neuropathology Induced by Chronic Restraint Stress in Rats. Pharmaceuticals. 2023; 16(6):848.
https://doi.org/10.3390/ph16060848
Chicago/Turabian Style
Arab, Hany H., Ali Khames, Mostafa K. Mohammad, Shuruq E. Alsufyani, Ahmed M. Ashour, Azza A. K. El-Sheikh, Hany W. Darwish, and Amany M. Gad.
2023. "Meloxicam Targets COX-2/NOX1/NOX4/Nrf2 Axis to Ameliorate the Depression-like Neuropathology Induced by Chronic Restraint Stress in Rats" Pharmaceuticals 16, no. 6: 848.
https://doi.org/10.3390/ph16060848
APA Style
Arab, H. H., Khames, A., Mohammad, M. K., Alsufyani, S. E., Ashour, A. M., El-Sheikh, A. A. K., Darwish, H. W., & Gad, A. M.
(2023). Meloxicam Targets COX-2/NOX1/NOX4/Nrf2 Axis to Ameliorate the Depression-like Neuropathology Induced by Chronic Restraint Stress in Rats. Pharmaceuticals, 16(6), 848.
https://doi.org/10.3390/ph16060848